BIAF - bioAffinity Technologies, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.91 -0.21 (-7.22%)	---	0.0 (0.0%)	-0.01 (-0.37%)	-0.08 (-2.75%)	-0.08 (-2.86%)	-0.08 (-2.85%)	-0.08 (-2.85%)

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Category: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.17
Diluted EPS:: -0.17
Basic P/E:: -15.8824
Diluted P/E:: -15.8824
RSI(14) 1m:: 0.0
VWAP:: 2.7
RVol:: 0.0511

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.7 -0.03 (-1.1%)	Oct 15 15:36
1m	Price increase 1m	2.78 +0.03 (+1.09%)	Oct 15 15:26
1m	Price increase 1m	2.82 +0.05 (+1.79%)	Oct 15 14:20
1m	Price increase 1m	2.79 +0.04 (+1.45%)	Oct 15 14:10
1m	Price decrease 1m	2.74 -0.04 (-1.44%)	Oct 15 14:09